Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.33M | $3.0M | 3.85% | +14.9K | 2026-06-30 |
| UBS Group AG | 585.4K | $1.0M | 1.69% | +33.8K | 2026-06-30 |
| Laird Norton Wetherby Trust Company, LLC | 578.7K | $1.0M | 1.67% | +12.4K | 2026-06-30 |
| D.A. Davidson & Co. | 539.3K | $1.0M | 1.56% | -- | 2026-06-30 |
| Geode Capital Management, LLC | 359.2K | $1.0M | 1.04% | -5.5K | 2026-06-30 |
| Marshall Wace, LLP | 328.3K | -- | 0.95% | +155.2K | 2026-06-30 |
| BlackRock, Inc. | 199.8K | -- | 0.58% | +29.7K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 192.4K | -- | 0.56% | +1.3K | 2026-06-30 |
| State Street Corp | 159.0K | -- | 0.46% | -- | 2026-06-30 |
| Gsa Capital Partners LLP | 117.5K | -- | 0.34% | +18.6K | 2026-06-30 |
